Physician profile

Sean G Barry

Pulmonary Disease · Lincoln, NE

NPI 1114901642

$4,445.35

in general payments reported to CMS, 2019-2025

43 companies · $991 in 2025

The $991 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,289.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Jazz Pharmaceuticals INC. $552.53 2019-2025
Genzyme Corporation $432.06 2019-2025
Glaxosmithkline, LLC. $425.52 2019-2025 Nucala, Trelegy Ellipta
Astrazeneca Pharmaceuticals LP $334.42 2019-2023 Breztri
Grifols USA, LLC $279.61 2019-2025 Prolastin-C Liquid
Amgen INC. $205.21 2021-2025 Tezspire, Tavneos
Boehringer Ingelheim Pharmaceuticals, INC. $204.51 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Mylan Specialty L.P. $188.00 2019-2024 Yupelri
Philips North America LLC $187.34 2019-2022
Sunovion Pharmaceuticals INC. $154.68 2019
Intuitive Surgical, INC. $132.74 2023 Da Vinci Surgical System
Insmed, INC. $117.68 2019-2025 Arikayce, Brinsupri
Regeneron Healthcare Solutions, INC. $89.04 2019-2025 Dupixent
Abiomed $82.18 2025
Janssen Pharmaceuticals, INC $78.13 2019
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Baxter Healthcare $78.11 2024-2025 Hillrom - Vest System Model 105 Home Care
Inspire Medical Systems, INC. $72.45 2023-2025 Inspire
Electromed, INC. $68.34 2019-2024 Smartvest
Tactile Systems Technology INC $63.50 2023-2025 Flexitouch Plus, Nimbl, Entre Plus
Veran Medical Technologies, INC. $59.05 2019
Verona Pharma, INC. $55.49 2025 Ohtuvayre
Harmony Biosciences LLC $53.58 2023-2024 Wakix
Avadel Cns Pharmaceuticals, LLC $43.33 2024-2025 Lumryz
Takeda Pharmaceuticals U.S.A., INC. $39.88 2021-2023 Glassia
Viatris Specialty LLC $34.93 2025 Yupelri
Astellas Pharma US INC $32.06 2024 Cresemba
Bayer Healthcare Pharmaceuticals INC. $30.62 2024
Fresenius USA Marketing, INC. $30.42 2021
3b Medical, INC. $30.03 2025 Luna
Allergan, INC. $30.00 2019-2020
United Therapeutics Corporation $29.48 2019-2024
Actelion Pharmaceuticals US, INC. $28.19 2023-2024 Uptravi, Opsumit
Merck Sharp & Dohme LLC $27.82 2019-2023
Aurinia Pharma U.S., INC. $23.57 2022
Novartis Pharmaceuticals Corporation $23.54 2019
Alkermes, INC. $21.54 2024 Vivitrol
Sanofi Pasteur INC. $20.07 2023
Hospira, INC. $17.57 2024
Pfizer INC. $14.97 2024
Genentech USA, INC. $14.25 2019
E.R. Squibb & Sons, L.L.C. $13.70 2019
Advanced Respiratory, INC $13.02 2019
Circassia INC. $12.19 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sean G Barry

$4,445.35

in general payments reported 2019-2025

Years
2019-2025
Top company
Jazz Pharmaceuticals INC.
Context
The $991 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/95806/sean-g-barry

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.